Breast Cancer: Current Research
Open Access

Radiation therapy; Brachytherapy; Radioresistance

Introduction

Radiotherapy, also known as radiation therapy, utilizes highenergy beams to target and destroy cancer cells. It can be administered externally using a machine outside the body (external beam radiation therapy) or internally through the placement of radioactive sources near or within the tumor site (brachytherapy). The primary goal of radiotherapy in breast cancer treatment is to eliminate residual cancer cells following surgery, reducing the risk of recurrence and improving long-term survival rates [1].

Methodology

Adjuvant radiotherapy in breast cancer treatment: Following breast-conserving surgery (lumpectomy) or mastectomy, adjuvant radiotherapy is often recommended to eradicate any remaining cancer cells in the breast tissue or surrounding lymph nodes. Despite successful surgical removal of the tumor, microscopic cancer cells may still be present, increasing the risk of recurrence. Adjuvant radiotherapy significantly reduces this risk by targeting residual disease, thus enhancing local control and improving overall survival outcomes [2,3].

Breast-conserving therapy and radiotherapy: Breast-conserving therapy, which combines lumpectomy with adjuvant radiotherapy, has become a widely accepted treatment approach for early-stage breast cancer. By preserving the breast while ensuring effective cancer control, this approach offers comparable outcomes to mastectomy in terms of survival rates and quality of life. Radiotherapy plays a crucial role in breast-conserving therapy by targeting residual disease in the breast tissue post-surgery, thereby minimizing the risk of recurrence and preserving breast aesthetics [4-6].

Neoadjuvant radiotherapy for locally advanced breast cancer: In cases of locally advanced breast cancer, where the tumor is large or has spread to nearby lymph nodes, neoadjuvant radiotherapy may be employed to shrink the tumor size before surgery. This approach aims to downsize the tumor, making it more amenable to surgical removal and potentially enabling breast-conserving surgery in select cases. Neoadjuvant radiotherapy not only facilitates tumor resection but also enhances the likelihood of achieving negative surgical margins, thereby improving overall treatment outcomes [7,8].

Regional nodal irradiation: In addition to targeting the primary tumor site, radiotherapy may also be used to treat regional lymph nodes in the axilla (armpit) or supraclavicular area. Regional nodal irradiation is indicated in cases where there is a high risk of lymph node involvement or if cancer cells are detected in the lymph nodes during surgery. By irradiating these regional lymph nodes, radiotherapy helps eradicate any microscopic cancer spread, thereby reducing the risk of locoregional recurrence and improving long-term disease control.

Advanced techniques in radiotherapy delivery: Recent advancements in radiotherapy technology have revolutionized treatment delivery, allowing for more precise targeting of tumors while sparing surrounding healthy tissues. Techniques such as intensitymodulated radiation therapy (IMRT), volumetric-modulated arc therapy (VMAT) and image-guided radiation therapy (IGRT) enable clinicians to tailor treatment plans to individual patient anatomy and tumor characteristics, optimizing treatment efficacy while minimizing side effects [9,10].

Side effects and management strategies: While radiotherapy is highly effective in treating breast cancer, it can also cause side effects such as skin irritation, fatigue, and breast discomfort. However, these side effects are usually temporary and can be managed with supportive care measures, including topical creams, pain medications, and lifestyle adjustments. Patient education and close monitoring by healthcare providers are essential for early detection and prompt management of side effects, ensuring optimal treatment tolerance and adherence.

Discussion

By leveraging the latest advancements in radiotherapy technology and adopting personalized treatment strategies, we can continue to improve outcomes and empower patients in their journey towards conquering breast cancer. Through ongoing research, innovation and collaboration, radiotherapy remains a vital tool in the fight against breast cancer, offering hope and healing to patients around the world.

Conclusion

Radiotherapy plays a pivotal role in the comprehensive management of breast cancer, offering significant benefits in terms of reducing recurrence rates, preserving breast tissue, and improving overall survival outcomes. As part of a multidisciplinary treatment approach, the judicious use of radiotherapy, tailored to individual patient characteristics and disease stage, contributes to achieving optimal therapeutic results and enhancing the quality of life for breast cancer patients.

References

1. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, et al. (2005) The transcriptional landscape of the mammalian genome. Science 309: 1559-1563.

Indexed at, Google Scholar, Crossref

2. Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, et al. (2012) GENCODE: The reference human genome annotation for The ENCODE Project. Genome Res 22: 1760-1774.

Indexed at, Google Scholar, Crossref

3. García-Padilla C, Aránega A, Franco D (2018) The role of long non-coding RNAs in cardiac development and disease. AIMS Genet 5: 124-140.

Indexed at, Google Scholar, Crossref

4. Expósito-Villén A, Aránega AE, Franco D (2018) Functional Role of Non-Coding RNAs during Epithelial-To-Mesenchymal Transition. Non-Coding RNA 4:1.

Google Scholar                

5. Shi X, Sun M, Liu H, Yao Y, Song Y (2013) Long non-coding RNAs: A new frontier in the study of human diseases. Cancer Lett 339: 159-166.

Indexed at, Google Scholar, Crossref

6. Statello L, Guo CJ, Chen LL, Huarte M (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22: 96-118.

Indexed at, Google Scholar, Crossref

7. Scott MS, Ono M (2011) From snoRNA to miRNA: Dual function regulatory non-coding RNAs. Biochimie. 93: 1987-1992.

Indexed at, Google Scholar, Crossref

8. Ma L, Bajic VB, Zhang Z (2013) On the classification of long non-coding RNAs. RNA Biol 10: 924-933.

Indexed at, Google Scholar, Crossref

9. Singh SR, Rameshwar P (2014) MicroRNA in Development and in the Progression of Cancer. New York, NY, USA.

Indexed at, Google Scholar, Crossref

10. Lu M, Zhang Q, Deng M, Miao J, Guo Y, et al. (2008) An Analysis of Human MicroRNA and Disease Associations. PLoS ONE 3: e3420.

Indexed at, Google Scholar, Crossref